What is he best known for?
The fields of study he is best known for:
His primary scientific interests are in Virology, Virus, Outbreak, Immunology and Genome.
His work deals with themes such as Genetics, Disease and Polymerase chain reaction, which intersect with Virology.
His study in Virus is interdisciplinary in nature, drawing from both Arenavirus, Antibody, Interferon and Antigen.
His research integrates issues of Disease reservoir, Phylogenetic tree, Microbiology, Phylogenetics and Coronavirus in his study of Outbreak.
His research in Immunology intersects with topics in Autism, Acquired immunodeficiency syndrome and Dysbiosis.
His study in the field of Genomic organization, Viral quasispecies and Comparative genomics is also linked to topics like Vector.
His most cited work include:
- The proximal origin of SARS-CoV-2. (1918 citations)
- A Metagenomic Survey of Microbes in Honey Bee Colony Collapse Disorder (1331 citations)
- Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection (668 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Virology, Virus, Immunology, Genetics and Genome.
His Virology research integrates issues from Phylogenetics, Antibody and Phylogenetic tree.
W. Ian Lipkin has included themes like Nucleic acid and Antigen in his Antibody study.
His biological study spans a wide range of topics, including Coronavirus, Human virome, Polymerase chain reaction and Microbiology.
His studies in Immunology integrate themes in fields like Autism, Disease and Borna disease.
His research in Autism tackles topics such as Pediatrics which are related to areas like Autism spectrum disorder.
He most often published in these fields:
- Virology (53.91%)
- Virus (30.17%)
- Immunology (18.44%)
What were the highlights of his more recent work (between 2018-2021)?
- Virology (53.91%)
- Virus (30.17%)
- Severe acute respiratory syndrome coronavirus 2 (1.96%)
In recent papers he was focusing on the following fields of study:
W. Ian Lipkin mainly focuses on Virology, Virus, Severe acute respiratory syndrome coronavirus 2, Antibody and Zoology.
The study incorporates disciplines such as Phylogenetic tree, Borrelia, Borrelia miyamotoi, Peptide and Coronavirus in addition to Virology.
His Virus research includes elements of Human virome and Polymerase chain reaction.
W. Ian Lipkin combines subjects such as Transmission, Incidence and Environmental health with his study of Severe acute respiratory syndrome coronavirus 2.
His Antibody research is multidisciplinary, relying on both Internal medicine, Cerebrospinal fluid and Disease.
The concepts of his Zoology study are interwoven with issues in Range, Tick, Wildlife, Culex annulirostris and Metagenomics.
Between 2018 and 2021, his most popular works were:
- The proximal origin of SARS-CoV-2. (1918 citations)
- Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism (373 citations)
- Trypsin treatment unlocks barrier for zoonotic bat coronavirus infection (90 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Virology, Virus, Autism, Autism spectrum disorder and Pediatrics.
His Virology research is multidisciplinary, incorporating elements of Coronavirus, Taphozous perforatus and Genotype.
His Coronavirus study combines topics in areas such as 2019-20 coronavirus outbreak, Coronavirus Infections, Biological evolution and Betacoronavirus.
In his study, which falls under the umbrella issue of Virus, Enterovirus is strongly linked to Autoimmunity.
His Autism research includes elements of Exome sequencing, Genetics and Copy-number variation.
His Pediatrics research is multidisciplinary, incorporating perspectives in Offspring, Logistic regression, Cohort study, Impulsivity and Risk factor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
